1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Anti-Infective Drug News MARCH 2016

Anti-Infective Drug News MARCH 2016

  • March 2016
  • -
  • Espicom Business Intelligence
  • -
  • 20 pages

Industry Trend Analysis - Favourable Commercial Environment Awaits MedImmune Anti-Flu Candidate
Industry Brief - FDA Approves Elusys' Anthim For Anthrax
Industry Trend Analysis - Prevnar 13 Patent Attack Will Pressure Indian Patent Office
Industry Brief - Summit's Ridinilazole Preserves Gut Microbiome In Phase II CoDIFy Trial
Industry Brief - Cellceutix Seeks SPA Approval For Brilacidin Phase III Trial In ABSSSIs
Industry Brief - Takeda's H. Pylori Regimens Approved In Japan
Industry Brief - Teva Canada Launches Tobramycin Inhalation Solution
Industry Brief - FDA Accepts Allergan's Avycaz sNDA For Review
Industry Brief - Altan Enters Caspofungin Licensing Agreement
Industry Brief - AureoGen/Merck Enter Licensing Deal For Novel Antifungal Drugs
Industry Brief - FDA Grants ODD For Matinas' NTM Infection Candidate
Industry Brief - ViveBio Enters Collaboration To Support Phase III Dengue Vaccine Studies
Industry Brief - Shionogi/Roche Collaborate On Anti-Flu Drug Development
Industry Brief - CHMP Recommends Approval Of Viekirax+Exviera And Descovy
Industry Brief - EMA Validates Gilead's Tenofovir Alafenamide MAA For HBV
Industry Trend Analysis - Brincidofovir Still Has A Future In CMV Prevention
Industry Trend Analysis - Zika Outbreak Sparks Diagnostics Development Rush
Industry Trend Analysis - Prize Fund Concept Rethinks Innovation/Reward Model
Industry Brief - Teva Canada Launches Abacavir+Lamivudine
Industry Brief - Gilead's F/TAF Franchise Gaining Commercial Momentum
Industry Trend Analysis - Gilead To Maintain HIV Dominance Despite ViiV Challenges
Industry Brief - Isentress Phase III ONCEMRK Trial Meets Primary Endpoint
Industry Trend Analysis - Expanding Antiretroviral Market To Provide Revenue Earning Opportunities
Industry Trend Analysis - Commitment To Vaccine Supply Will Create Opportunities For Drugmakers
Industry Brief - Paediatric Hexavalent Vaccine Approved For Sale In EU
Industry Brief - Sanofi /Merck To End European Joint Vaccines Operations
Industry Brief - ViiV Completes Acquisition Of BMS' R&D HIV Assets

Table Of Contents

Anti-Infective Drug News MARCH 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.